NCBP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.146400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.888200E-01
Normal-vs-Stage2
8.479400E-01
Normal-vs-Stage3
3.259400E-01
Normal-vs-Stage4
5.486200E-01
Stage1-vs-Stage2
9.842400E-01
Stage1-vs-Stage3
2.132400E-01
Stage1-vs-Stage4
2.662200E-01
Stage2-vs-Stage3
2.526600E-01
Stage2-vs-Stage4
3.423600E-01
Stage3-vs-Stage4
1.349590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.298400E-01
Normal-vs-AfricanAmerican
8.611400E-01
Normal-vs-Asian
3.324400E-01
Caucasian-vs-AfricanAmerican
9.919400E-01
Caucasian-vs-Asian
2.870200E-01
AfricanAmerican-vs-Asian
4.677600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.934200E-01
Normal-vs-Female
8.581400E-01
Male-vs-Female
6.783800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.986400E-01
Normal-vs-Age(41-60Yrs)
8.079000E-01
Normal-vs-Age(61-80Yrs)
6.036600E-01
Normal-vs-Age(81-100Yrs)
7.530600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.609000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.260600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.959400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.224400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.648200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.427400E-01
Normal-vs-Daily Drinker
3.275800E-01
Normal-vs-Weekly Drinker
6.591600E-01
Normal-vs-Occasional Drinker
6.350200E-01
Normal-vs-Social Drinker
9.297800E-01
Non Drinker-vs-Daily Drinker
5.457400E-01
Non Drinker-vs-Weekly Drinker
7.642000E-01
Non Drinker-vs-Occasional Drinker
5.944400E-02
Non Drinker-vs-Social Drinker
2.793000E-01
Daily Drinker-vs-Weekly Drinker
3.161000E-01
Daily Drinker-vs-Occasional Drinker
2.640300E-02
Daily Drinker-vs-Social Drinker
5.211700E-02
Weekly Drinker-vs-Occasional Drinker
1.249610E-01
Weekly Drinker-vs-Social Drinker
3.731600E-01
Occasional Drinker-vs-Social Drinker
3.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.874800E-01
Normal-vs-Grade 2
6.415600E-01
Normal-vs-Grade 3
1.216960E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.901880E-02
Grade 1-vs-Grade 3
7.936500E-03
Grade 1-vs-Grade 4
7.874800E-01
Grade 2-vs-Grade 3
3.386600E-01
Grade 2-vs-Grade 4
6.415600E-01
Grade 3-vs-Grade 4
1.216960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.741000E-01
Normal-vs-NonDiabetic
8.414000E-01
Diabetic-vs-NonDiabetic
1.512350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.499400E-01
Normal-vs-NoPancreatitis
7.914800E-01
Pancreatitis-vs-NoPancreatitis
9.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.586400E-01
Normal-vs-N1
8.918000E-01
N0-vs-N1
3.942600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.650800E-01
Normal-vs-TP53-NonMutant
6.236600E-01
TP53-Mutant-vs-TP53-NonMutant
9.537600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
